What is the Depo-provera Lawsuit?

The Depo-Provera lawsuit refers to ongoing legal claims against Pfizer involving its injectable contraceptive, medroxyprogesterone acetate. These lawsuits primarily allege that long-term use of the drug significantly increases the risk of developing brain tumors, specifically meningiomas. Recent medical studies, including a 2024 JAMA analysis, have linked prolonged exposure (often defined as more than two years) to a heightened risk of these hormone-sensitive tumors.

Key aspects of the litigation include:

Federal Consolidation: Many individual product liability claims have been consolidated into Multidistrict Litigation (MDL No. 3140) in the U.S. District Court for the Northern District of Florida to streamline pretrial proceedings.

Legal Allegations: Plaintiffs argue that Pfizer failed to provide adequate warnings about the potential for brain tumors and that there were defects in the drug’s design.

Eligibility Requirements: Potential claimants typically need documented proof of Depo-Provera use for at least two years and a confirmed diagnosis of a brain tumor or meningioma via MRI or CT scans.

Compensation Goals: Lawsuits seek to recover damages for medical expenses, lost wages, pain and suffering, and potential long-term care costs.

At Stipe Law Firm, we assist affected individuals in Oklahoma by conducting free case evaluations to determine eligibility and navigate the complexities of these pharmaceutical claims.